Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
A phase 2 clinical trial (NCT06092034) is currently underway to evaluate the safety and efficacy of RP-A501 in male participants aged 8 years and older
Stem Cells and Dev
Add-on value of tirzepatide versus semaglutide [PMID: 35468323] Laboratory literature summary: Add-on value of tirzepatide versus semaglutide
Epub 2005 Apr 26
While the FTC could not comment on its lawsuit or the specific practices of any given company, the commission is advancing new rules about telehealth companies using whats commonly called a negative option. As described in a recent FTC Advanced Notice of Proposed Rulemaking (ANPRM), a negative option is a common form of marketing in which the absence of affirmative consumer action constitutes consent to be charged for goods or services. In other words: drugs prescribed and shipped without patient consent, credit cards charged without direct authorization, inscrutable cancellation policies, and other automatic opt-ins that seem to typify telehealth frustrations
US$ 25.27
US$ 29.27
US$ 29.20
US$ 27.58
